Overview
Hematopoietic stem cell transplantation (HSCT) is a therapeutic procedure in which hematopoietic stem cells, the self-renewing cells that give rise to all blood and immune cell lineages, are infused to restore or replace a patient's hematopoietic and immune system. It is used to treat malignant disorders such as leukemias and lymphomas, as well as bone marrow failure states, hemoglobinopathies, and certain immune and metabolic diseases. Transplants are classified by the source of the cells: autologous, using the patient's own previously collected stem cells, and allogeneic, using cells from a donor. Stem cells may be obtained from bone marrow, mobilized peripheral blood, or umbilical cord blood, and adequate collection sometimes requires agents that enhance mobilization of stem cells into the circulation. In allogeneic transplantation, compatibility between donor and recipient at the human leukocyte antigen (HLA) loci is a central determinant of outcome; degrees of HLA mismatch, including in unrelated donors, and the presence of donor-specific antibodies influence engraftment and complications. The procedure typically involves a conditioning regimen followed by infusion and a period of profound immunosuppression during which patients are vulnerable to infection. Major complications include graft-versus-host disease in allogeneic settings, graft failure, immune cytopenias, and opportunistic infections. HSCT integrates transplant immunology, hematology, and supportive care, with engraftment and immune reconstitution as key goals.
Research published in this journal
5 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Successful Allogeneic Hematopoietic Stem Cell Transplantation from A 5/10 Mismatched Unrelated Donor in A Patient with Donor-Specific Anti-HLA Antibodies.
Evaluating the Role and Efficacy of Plerixafor in Rescue Mobilization of Autologous Peripheral Blood Stem Cells
Immune Thrombocytopenia after Allogeneic Stem Cell Transplantation: Case Report and Brief Overview of Treatment Strategies
Itraconazole Prophylaxis for an Outbreak of Invasive Aspergillosis in a Hematology Ward after Hospital Construction Work
How this research is being cited
The 5 articles above have been cited 7 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2023 · Frontiers in Immunology
-
R. Bailén et al. · 2023 · Frontiers in Immunology
-
2022 · Hematology/Oncology and Stem Cell Therapy
-
2021 · Frontiers in Immunology
-
R. Bailén et al. · 2021 · Frontiers in Immunology
-
2020 · Hematology/Oncology and Stem Cell Therapy
-
2018 · Journal of Hematology and Oncology Research
A sample of recent works citing this journal's research on Hematopoietic Stem Cell Transplantation, linking to each citing work.